Source: pixabay

Geographic spread prediction

Flu forecast looks six weeks ahead

Scientists at Columbia University’s Mailman School of Public Health developed a system to accurately predict the geographic spread of seasonal influenza in the United States up to six weeks ahead of time.

For the public, the flu forecast may promote greater vaccination, the exercise of care around people sneezing and coughing, and a better awareness of personal health. For health officials, it could inform decisions on how to stockpile and distribute vaccines and antiviral drugs, and in the case of a virulent outbreak, whether other measures, like closing schools, are necessary.

In a retrospective test for the 2008-2009 through 2012-2013 influenza seasons in 35 states, the Mailman School researchers found their forecasting system accurately predicted local onset of flu six weeks ahead of time. Compared to the previous version of the system, the new version improved forecasting accuracy with regard to onset, by 35 percent; peak timing, by 31 percent; and intensity, by 13 percent. Similar improvements were seen at the county level in a test using data from Virginia.

The researchers expect to use the system in their online forecasts for the 2018-19 flu season. Currently, it is being employed as one of the Mailman School entries in the 2017-18 Centers for Disease Control and Prevention flu forecast challenge, which the research team previously won outright in 2014 and tied for first in 2015 and 2017.

System includes commuting patterns

respiratory medication
The system could also be adapted for use with other respiratory viruses.
Source: pixabay

“The system could also be adapted for use with other respiratory viruses, and with some modification, for infectious diseases more broadly,” says lead author Sen Pei, PhD, a postdoctoral scientist in Environmental Health Sciences at Columbia’s Mailman School of Public Health.

The forecasting system employs techniques used in modern weather prediction to generate local forecasts. It starts with data from the Department of Defense on local incidence of influenza-like illness combined with laboratory-verified cases of influenza and adds a spatial element by incorporating information from Census data on commuting patterns. The system accounts for differences in population location between day and night and irregular travel such as for business trips and vacations.

“Influenza, like many infectious diseases, is spread from person-to-person and as people move from place to place,” says Jeffrey Shaman, the study’s senior author and associate professor of Environmental Health Sciences at the Mailman School. “By assimilating information on commuting patterns, we’ve taken a big step forward and improved our ability to accurately forecast where the flu might crop up next.”


Source: Columbia University

09.03.2018

Read all latest stories

Related articles

Photo

Soaking up SARS-CoV-2

Nanosponges could intercept coronavirus infection

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack…

Photo

COVID-19 infections

Genetic network analysis provides 'snapshot' of pandemic origins

Researchers from Cambridge, UK, and Germany have reconstructed the early “evolutionary paths” of COVID-19 in humans – as infection spread from Wuhan out to Europe and North America – using…

Photo

Pilot clinical trial

China to test targeted therapy for COVID-19

A University of British Columbia (UBC) researcher is part of an international team working with a biotechnology company on a pilot clinical trial of a potential new treatment for patients with severe…

Related products

Atlas Genetics - Atlas Genetics io system

Infectious diseases testing

Atlas Genetics - Atlas Genetics io system

Atlas Genetics Ltd
Eppendorf – Mastercycler nexus X2

Research Use Only (RUO)

Eppendorf – Mastercycler nexus X2

Eppendorf AG
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Siemens Healthineers – Versant HCV Genotype 2.0 Assay (LiPA)

Infectious Disease/Hepatitis

Siemens Healthineers – Versant HCV Genotype 2.0 Assay (LiPA)

Siemens Healthineers